GeneralConnection.com ➔ Dictionary
Dictionary Search

infliximab

Synonyms

Noun

1. Remicade

2. anti-TNF compound

Usage
Subcutaneous Infliximab for CD by Location - Docwire News
Subcutaneous Infliximab Shows Promise for Durable, Patient-Centered IBD Care - BioPharm International
Subcutaneous Infliximab Recaptures Disease Control After Treatment Interruption in IBD - HCPLive
Additive effects of fecal microbiota transplantation and infliximab on gut microbiome and metabolome in refractory inflammatory bowel disease patients - ASM Journals
Ileocaecal resection versus infliximab for ileal Crohn's disease: retrospective 10-year follow-up of the LIR!C trial - The Lancet
Severe cerebellitis as a manifestation of infliximab-associated overlap of neurosarcoidosis and myelin oligodendrocyte glycoprotein antibody-associated disease – case report - Frontiers
Pharmacokinetic Model Selection for Personalized Infliximab Dosing in IBD - Wiley
The Biosimilar Shift: Trending Infliximab Biosimilar Utilization and Associated Cost Savings for Commercial Insurance - AJMC
Effectiveness of Infliximab for Refractory Nonischemic Cerebral Enhancing Foreign-Body Granulomatous Lesions After Endovascular Therapy - Neurology® Journals
‘Pleasantly surprised’: Subcutaneous infliximab effective, regardless of Crohn’s location - Healio
Celltrion announces publication of post-hoc analysis of LIBERTY-CD study of ZYMFENTRA® (infliximab-dyyb), indicating consistent efficacy across disease location, including the terminal ileum in Clinical Gastroenterology and Hepatology journal - PR Newswire
Melkersson-Rosenthal Syndrome: A Case Treated With Infliximab - Cureus
Danish Registry Analysis Finds Consistent Safety After Switching to Infliximab Biosimilar GP1111 - Center for Biosimilars
Early Colectomy After Infliximab in Ulcerative Colitis Linked to C. difficile Infection - Docwire News
Subcutaneous Infliximab May Improve Convenience, Adherence, and Sustained Remission in IBD Care - BioPharm International
Fulminant Tetraplegia in a Patient on Infliximab: A Case of Masked Cervical Spinal Epidural Abscess Presenting With Dysphagia - Cureus
Secondary Hemophagocytic Lymphohistiocytosis in a Patient With Crohn’s Disease Receiving Infliximab: A Diagnostic Challenge - Cureus
Bilateral Renal Artery Thrombosis in a Patient With Behçet’s Disease Managed With Infliximab Infusions - Cureus
Accelerated infliximab induction reduces long-term odds of colectomy in ulcerative colitis - Healio
Infliximab for intravenous immunoglobulin-resistant Kawasaki disease complicated with cholestatic hepatitis: a case report and discussion on coronary artery aneurysm prevention - Frontiers
Infliximab, Upadacitinib Offer Rapid Relief in Ulcerative Colitis - Medscape
A Fulminant Case of Refractory Sarcoidosis Triggered by Infliximab-Neutralizing Antibodies - Cureus
Comparison of endoscopic healing and durability between combination therapy with infliximab and azathioprine versus infliximab monotherapy in pediatric Crohn’s disease - Nature
Infliximab and Adalimumab Biosimilars Maintain Comparable Safety, Efficacy, Immunogenicity in IBD - Pharmacy Times
Implications of the First Liquid IV Infliximab Biosimilar - BioPharm International
Top 20 Companies in Global Infliximab Biosimilar Market: Strategic Overview and Future Trends (2026–2035) - Spherical Insights
European Commission Grants Approval of Remsima™ IV Liquid Formulation, World’s First Liquid Formulation of IV Infliximab - Business Wire
Celltrion to present seven abstracts in inflammatory bowel disease (IBD) at 2026 Digestive Disease Week® (DDW) - PR Newswire
Celltrion launches liquid formulation of Remsima IV in Europe to strengthen infliximab market leadership - koreabiomed.com
Fulminant Tuberculous Pericarditis Presenting as Cardiac Tamponade in an Infliximab-Treated Patient - Cureus
New ECCO data show subcutaneous (SC) infliximab (Remsima™ SC) effectively recaptures and maintains disease control after drug holiday - BioSpace
Successful Treatment of Pediatric Neurosarcoidosis With Corticosteroids, Infliximab, and Methotrexate - ScienceDirect.com
Australian Patients With IBD Switched to Biosimilar Infliximab Maintain Long-Term Persistence - Center for Biosimilars
Case Report: Facial Malassezia folliculitis following infliximab treatment in Crohn's disease - Frontiers
Infliximab treatment for autoimmune hepatitis - Clínica FEHV
Discontinuation of Infliximab Therapy in Patients with Crohn’s Disease - NEJM Evidence
Research Communication: Combination Therapy of Upadacitinib With Infliximab, Risankizumab, Ustekinumab or Vedolizumab for Refractory Crohn's Disease: A Descriptive Case Series - Wiley Online Library
Bastian Schilling: Infliximab for Steroid-Refractory irHepatitis - Efficacy and Safety Demonstrated - Oncodaily
Pfizer’s IV Infliximab Biosimilar Approved in NZ - Pearce IP
FDA Approves First Subcutaneous Infliximab Product - Center for Biosimilars
Case Studies Highlight Link Between Crohn’s Disease Treatment and IgAN - Docwire News
Meta‐Analysis: Intravenous Versus Subcutaneous Infliximab in Inflammatory Bowel Disease - Wiley Online Library
Infliximab versus Cyclophosphamide for Severe Behçet’s Syndrome - NEJM Evidence
Tracing the historical foundations of infliximab in Crohn’s disease treatment: a cited reference analysis - Frontiers
Effectiveness of switching to subcutaneous infliximab in inflammatory bowel disease patients with inadequate biochemical response during intravenous administration - Nature
Subcutaneous Infliximab Therapy Efficacious for Inflammatory Bowel Disease - Gastroenterology Advisor
Infliximab treatment in pathology-confirmed neurosarcoidosis - Neurology® Journals
Celltrion’s Remsima SC First to LATAM Market - Pearce IP
Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease - The New England Journal of Medicine
Intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis (PREDICT-UC): an open-label, multicentre, randomised controlled trial - The Lancet
Zymfentra, a Subcutaneous Formulation of Infliximab, Approved for IBD - Medical Professionals Reference
Vedolizumab is superior to infliximab in biologic naïve patients with ulcerative colitis - Nature
ODDIFACT Receives European Commission Orphan Drug Designation for Infliximab in Kawasaki Disease - The Manila Times
FDA Approves First Subcutaneous Infliximab for Maintenance Therapy in UC and Crohn Disease - HCPLive
Clinical consequences of infliximab immunogenicity and the effect of proactive therapeutic drug monitoring: exploratory analyses of the randomised, controlled NOR-DRUM trials - The Lancet
Celltrion’s Remsima cements status as S.Korea’s blockbuster global medicine - KED Global
Association of the TNFRSF1B -rs1061622 variant with nonresponse to infliximab in ulcerative colitis - Nature
Evaluation of infliximab/tocilizumab versus tocilizumab among COVID-19 patients with cytokine storm syndrome - Nature
Biosimilars of infliximab - Generics and Biosimilars Initiative
The Remicade Biosimilars Available Now - GoodRx
The total gut mucosal and fecal bacterial load increases in successful treatment of inflammatory bowel disease with infliximab - ASM Journals
Infliximab Cost - News-Medical
Vedolizumab Beats Infliximab as Second-Line Therapy for Ulcerative Colitis - Medscape
Infliximab concentrations in two non-switching cohorts of patients with inflammatory bowel disease: originator vs. biosimilar | Scientific Reports - Nature
Timing of Infliximab Infusion Prior to Surgery and Post-Operative Infections - Rheumatology Advisor
Effectiveness of tacrolimus therapy in refractory ulcerative colitis compared to infliximab with propensity score matching - Nature
Therapeutic Drug Monitoring and Outcome of Infliximab Therapy in Pediatric Onset Inflammatory Bowel Disease - Frontiers
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease - The New England Journal of Medicine
Weight Gain on Infliximab Tied to Sex, Crohn Disease, and Disease Severity - Gastroenterology Advisor
Celltrion's infliximab subcutaneous injection (SC) formulation treatment "Zimpentra" has proven the - 매일경제
Preventing Crohn's Disease Recurrence Regueiro Report Infliximab - Gastroenterology & Endoscopy News
Celltrion gains 70% Europe infliximab share as SC formulations surge - CHOSUNBIZ - Chosunbiz
Intravenous to Subcutaneous Infliximab Switch Shows Promise in IBD Management - Medscape
Efficacy and Safety of Infliximab Versus Adalimumab in Adult Subjects With Moderate to Severe Ulcerative Colitis: A Systematic Review and Meta-Analysis - Cureus
How Long Does Remicade Take to Work for Ulcerative Colitis? - HealthCentral
European Commission Grants Approval of Remsima IV Liquid Formulation, Worlds First Liquid Formulation of IV Infliximab - MEDI:GATE NEWS
ZYMFENTRA™(infliximab-dyyb), the first and only FDA-approved subcutaneous infliximab, now commercially available in the U.S. - PR Newswire
Aggressive Infliximab Dosing Shows No Added Benefit in Acute Severe Ulcerative Colitis - Medscape
Monocytes from infliximab-resistant patients with Crohn’s disease exhibit a disordered cytokine profile - Nature
Detecting early safety signals of infliximab using machine learning algorithms in the Korea adverse event reporting system - Nature
FLIXABI®, Biogen’s Infliximab Biosimilar Referencing Remicade®, Approved in the European Union - Biogen
Celltrion announced on the 19th that its infliximab subcutaneous injection (SC) formulation treatmen.. - 매일경제
Opacity over live vaccines in infants exposed to infliximab - The Lancet
Are Live Vaccines Safe for Infants Exposed to Infliximab During Parent’s IBD Treatment? - Gastroenterology Advisor
Case Report: Development of medication-related osteonecrosis of the jaw in a patient on long-term infliximab therapy - Frontiers
Early Crohn's treatment 'could save NHS millions' - BBC
A 10-year follow-up of infliximab monotherapy for refractory uveitis in Behçet’s syndrome - Nature
Treating IBD During Pregnancy - Johns Hopkins Medicine
Infliximab-Induced Vasculitis in a Rheumatoid Arthritis Patient: A Comprehensive Case Report - Cureus
Anti-NMDAR encephalitis in Crohn’s disease undergoing long-term infliximab treatment: A case report - Frontiers
Initial dose of infliximab 5 mg/kg ‘should be adequate’ in most cases of acute severe UC - Healio
Infliximab Maintenance Therapy Immunosuppressant - Gastroenterology & Endoscopy News
VisualAbstract: Dual therapy with infliximab and IVIG in children with multi-system inflammatory syndrome - 2 Minute Medicine
No Difference in Pediatric Growth Rates with Infliximab Biosimilar vs Reference Agent - HCPLive
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis - The New England Journal of Medicine
Posters Demonstrate Switching Safety Between Originator, Biosimilar Infliximab in IBD - Center for Biosimilars
Relapse of severe neurosarcoidosis with switch from originator infliximab to biosimilar - Neurology® Journals
Dual therapy with infliximab and IVIG in children with multi-system inflammatory syndrome - 2 Minute Medicine
Case Report: Hemolytic anemia secondary to infliximab treatment in a patient with ulcerative colitis - Frontiers
Upadacitinib in Perianal Fistulizing CD; IBS Symptoms in IBD - Gastroenterology & Endoscopy News
Foreign Language Equivalents
Foreign Language Equivalents of 'infliximab'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
infliximsb,   nfliximab,   ifnliximab,   infliiximab,   onfliximab,   inflximab,   infliximmab,   inflixximab,   ifliximab,   infloximab,   inlfiximab,   infliximaab,   inffliximab,   inflixi,ab,   influximab,   infilximab,   ingliximab,   infliimab,   nifliximab,   infliixmab,   infliximba,   inflliximab,   inflixmiab,   unfliximab,   iinfliximab,   innfliximab,   imfliximab,   inflizimab,   inflixmab,   infkiximab,   inflxiimab,   ibfliximab,   indliximab,   infliximan,   inliximab,   infliximabb,   inflixima,   inflixomab,   inflicimab,   infiximab,   inflixiamb,   infliximb,   infliximav,   inflixiimab,   inf;iximab,   inflixiab,   inflixumab,   inflixinab
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z